Bosh sahifaNBY • NYSEAMERICAN
add
NovaBay Pharmaceuticals Inc
1,21 $
Seans yopilganidan keyin:(3,31%)-0,040
1,17 $
Yopilgan:5-dek, 17:40:39 (GMT-5) · USD · NYSEAMERICAN · Ogohlantirish
Yopilish kursi
1,09 $
Kunlik diapazon
1,06 $ - 1,22 $
Yillik diapazon
0,46 $ - 4,44 $
Bozor kapitalizatsiyasi
152,47 mln USD
Oʻrtacha hajm
131,02 ming
Narx/foyda
2,25
Dividend daromadliligi
-
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 521,00 ming | -78,66% |
Joriy xarajat | 1,21 mln | -28,89% |
Sof foyda | -1,29 mln | -6,68% |
Sof foyda marjasi | -248,18 | — |
Har bir ulushga tushum | — | — |
EBITDA | -1,17 mln | 31,23% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,31 mln | 197,55% |
Jami aktivlari | 3,49 mln | -10,06% |
Jami passivlari | 1,85 mln | -33,94% |
Umumiy kapital | 1,63 mln | — |
Tarqatilgan aksiyalar | 126,01 mln | — |
Narxi/balansdagi bahosi | -2,42 | — |
Aktivlardan daromad | -56,21% | — |
Kapitaldan daromad | -74,07% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -1,29 mln | -6,68% |
Operatsiyalardan naqd pul | -1,80 mln | 12,71% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | -1,32 mln | -163,17% |
Naqd pulning sof oʻzgarishi | -3,12 mln | -12 096,15% |
Boʻsh pul | -1,22 mln | 35,34% |
Haqida
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Tashkil etilgan
2000
Sayt
Xodimlar soni
14
